TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $32,226,000 | -5.3% | 3,322,300 | +4.9% | 0.33% | +2.5% |
Q1 2021 | $34,012,000 | -21.9% | 3,166,900 | +7.0% | 0.32% | -16.5% |
Q4 2020 | $43,545,000 | +144.6% | 2,960,200 | +136.3% | 0.38% | +70.1% |
Q3 2020 | $17,799,000 | +81.7% | 1,252,600 | +3.4% | 0.22% | +62.3% |
Q2 2020 | $9,797,000 | +202.8% | 1,211,000 | +51.2% | 0.14% | +155.6% |
Q1 2020 | $3,236,000 | – | 801,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 4,040,000 | $59,428,000 | 8.74% |
Fairmount Funds Management LLC | 1,478,181 | $21,744,000 | 7.78% |
COMMODORE CAPITAL LP | 852,871 | $12,546,000 | 6.82% |
Ghost Tree Capital, LLC | 1,950,000 | $28,685,000 | 6.39% |
Endurant Capital Management LP | 655,741 | $9,646,000 | 3.48% |
FRAZIER MANAGEMENT LLC | 3,053,107 | $44,879,000 | 3.46% |
ACUTA CAPITAL PARTNERS, LLC | 803,000 | $11,812,000 | 3.21% |
NEA Management Company, LLC | 5,736,363 | $84,382,000 | 2.23% |
Tri Locum Partners LP | 296,838 | $4,366,000 | 1.59% |
Avidity Partners Management LP | 3,185,200 | $46,854,000 | 1.52% |